Related Experiment Video
Updated: Dec 24, 2025
07:55
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.5K
Immuno-Oncology beyond TILs: Unleashing TILCs
Olivier Demaria1, Eric Vivier2
1Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.
Cancer Cell
|April 15, 2020
Summary
Innate lymphoid cells (ILCs) in tumors may aid anti-tumor immunity. Researchers found that blocking PD-1 can activate these tumor-infiltrating ILCs (TILCs) to boost T cell responses against cancer.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Innate lymphoid cells (ILCs) are present in various tumor types.
- The precise role of ILCs in anti-tumor immunity is not fully understood.
Purpose of the Study:
- To investigate the function of tumor-infiltrating ILCs (TILCs) in the tumor microenvironment.
- To determine if PD-1 blockade can modulate TILC activity to enhance anti-tumor immune responses.
Main Methods:
- Analysis of TILCs in different tumor models.
- Assessment of TILC function following PD-1 blockade treatment.
Main Results:
- A specific subset of TILCs was identified as potentially participating in organ-specific anti-tumor immune responses.
- PD-1 blockade therapy was shown to activate these TILCs.
- Activated TILCs sustained tumor-specific T cell responses.
Conclusions:
- Tumor-infiltrating ILCs represent a potential therapeutic target in cancer immunotherapy.
- Modulating TILCs via PD-1 blockade may enhance the efficacy of cancer treatments by bolstering T cell-mediated immunity.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:27Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
01:30Cancer Vaccines
871
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
871
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K